Get the Stockscreener App
2.41
7.11%
0.16
After Hours:
2.39
-0.02
-0.83%
Medicus Pharma Ltd stock is traded at $2.41, with a volume of 263.80K.
It is up +7.11% in the last 24 hours and up +7.59% over the past month.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.
See More
Previous Close:
$2.25
Open:
$2.27
24h Volume:
263.80K
Relative Volume:
0.66
Market Cap:
$41.77M
Revenue:
-
Net Income/Loss:
$-16.51M
P/E Ratio:
-1.3169
EPS:
-1.83
Net Cash Flow:
$-15.68M
1W Performance:
+28.19%
1M Performance:
+7.59%
6M Performance:
-26.75%
1Y Performance:
+0.00%
1-Day Range:
$2.15
$2.45
1-Week Range:
$1.82
$2.45
52-Week Range:
$1.7901
$8.94
Medicus Pharma Ltd Stock (MDCX) Company Profile
Name
Medicus Pharma Ltd
Sector
Industry
Phone
610-540-7515
Address
300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN
Compare MDCX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDCX
Medicus Pharma Ltd
|
2.41 | 41.77M | 0 | -16.51M | -15.68M | -1.83 |
|
LLY
Lilly Eli Co
|
755.39 | 676.48B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
178.06 | 423.36B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
218.34 | 373.87B | 58.33B | 3.73B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
124.12 | 244.98B | 53.40B | 13.68B | 16.89B | 6.9231 |
|
MRK
Merck Co Inc
|
82.81 | 209.89B | 63.43B | 16.42B | 14.72B | 6.49 |
Medicus Pharma Ltd Stock (MDCX) Latest News
Medicus Pharma Appoints Carolyn Bonner as Acting CFO - TipRanks
Medicus Pharma says Carolyn Bonner appointed as acting CFO of coSEC filing - MarketScreener
Medicus Pharma Ltd. Provides Update on United Arab Emirates (UAE) SKNJCT-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC) - Lohud
Medicus Pharma Ltd. Acquires Antev Limited, Expanding Drug Development Pipeline - TipRanks
Medicus Pharma says UAE SKNJCT-004 Phase 2 trial commences patient recruitment - MSN
Medicus Pharma Ltd. Advances Clinical Trials for Skin Cancer Treatment - TipRanks
What are Medicus Pharma Ltd.’s earnings expectations2025 Risk Factors & Stock Portfolio Risk Management - Lancaster City Council
Trade Report: Can Medicus Pharma Ltd. Equity Warrant ride the EV waveQuarterly Profit Review & Verified Short-Term Plans - Lancaster City Council
MDCx - x.com
Medicus Moves Forward in UAE Trial for Novel, Non-Invasive BCC Therapy - Dermatology Times
Is Medicus Pharma Ltd. Equity Warrant forming higher highs and higher lowsDollar Strength & Comprehensive Market Scan Reports - beatles.ru
Small cap wrap: North Bay Resources, 374 Water, American Resources, Medicus Pharma... - Proactive Investors
60% Clinical Success: Medicus Pharma's Non-Invasive Skin Cancer Treatment Targets $2B Market Opportunity - Stock Titan
Medicus Pharma begins Phase 2 clinical study in UAE to treat BCC - Proactive financial news
Can Medicus Pharma Ltd. Equity Warrant Rally Enough to Break EvenJuly 2025 Patterns & Daily Stock Trend Watchlist - beatles.ru
Is Medicus Pharma Ltd. stock undervalued right nowEarnings Summary Report & Long Hold Capital Preservation Plans - beatles.ru
Should you wait for a breakout in Medicus Pharma Ltd. Equity WarrantMarket Movers & Weekly Consistent Profit Watchlists - Newser
Is Medicus Pharma Ltd. forming a reversal patternPortfolio Value Summary & High Conviction Investment Ideas - Newser
Can Medicus Pharma Ltd. keep up with sector leaders2025 Key Highlights & Community Consensus Trade Alerts - خودرو بانک
Is Medicus Pharma Ltd. stock suitable for long term investingM&A Rumor & Weekly High Return Stock Forecasts - خودرو بانک
Is Medicus Pharma Ltd. affected by consumer sentiment2025 Key Highlights & Entry Point Confirmation Signals - خودرو بانک
Medicus Pharma appoints Faisal Mehmud as CMO - MSN
Does Medicus Pharma Ltd. Equity Warrant meet Warren Buffett’s criteria2025 Performance Recap & Long-Term Safe Investment Plans - خودرو بانک
How moving averages guide Medicus Pharma Ltd. trading2025 Market Outlook & Stepwise Entry and Exit Trade Signals - Newser
Visualizing Medicus Pharma Ltd. stock with heatmapsJuly 2025 Weekly Recap & High Conviction Buy Zone Alerts - Newser
Analysts Offer Insights on Healthcare Companies: Novan (NOVN) and Medicus Pharma Ltd (MDCX) - The Globe and Mail
Medicus Pharma Ltd. stock prediction for this weekShort Setup & Smart Money Movement Alerts - Newser
Analyzing Medicus Pharma Ltd. Equity Warrant with risk reward ratio chartsTrade Entry Report & Consistent Profit Alerts - Newser
Heatmap analysis for Medicus Pharma Ltd. and competitorsEarnings Risk Report & Consistent Profit Focused Trading Strategies - Newser
Is Medicus Pharma Ltd. stock ready for a breakoutGDP Growth & Weekly High Return Forecasts - Newser
How to escape a deep drawdown in Medicus Pharma Ltd. Equity WarrantJuly 2025 Summary & Real-Time Volume Triggers - Newser
Medicus Pharma Ltd. (NASDAQ: MDCX) Builds Momentum With Antev Acquisition and Pipeline Progress - MarketScreener
Is Medicus Pharma Ltd. still a buy after recent gainsIPO Watch & Verified Chart Pattern Trade Signals - خودرو بانک
Is a relief rally coming for Medicus Pharma Ltd. holdersTrade Performance Summary & Verified Swing Trading Watchlists - Newser
Why Medicus Pharma Ltd. Equity Warrant stock attracts strong analyst attentionWall Street Watch & Low Risk Entry Point Guides - Newser
Can Medicus Pharma Ltd. maintain sales growth2025 Retail Activity & Technical Buy Zone Confirmation - خودرو بانک
Can machine learning forecast Medicus Pharma Ltd. Equity Warrant recoveryDay Trade & Stepwise Swing Trade Plans - Newser
Is Medicus Pharma Ltd. Equity Warrant stock a value trapJuly 2025 Price Swings & Daily Momentum Trading Reports - خودرو بانک
Key resistance and support levels for Medicus Pharma Ltd. Equity WarrantJuly 2025 Closing Moves & Target Return Focused Stock Picks - Newser
Using flow based indicators on Medicus Pharma Ltd.Market Sentiment Review & Technical Entry and Exit Alerts - Newser
Is Medicus Pharma Ltd. a top pick in the sectorTrade Risk Report & Long-Term Safe Investment Ideas - خودرو بانک
Can Medicus Pharma Ltd. Equity Warrant deliver consistent EPS growth2025 Stock Rankings & High Conviction Trade Alerts - خودرو بانک
Analyzing recovery setups for Medicus Pharma Ltd. Equity Warrant investorsIndex Update & AI Enhanced Trading Alerts - Newser
Using Ichimoku Cloud for Medicus Pharma Ltd. Equity Warrant technicals2025 Buyback Activity & Verified Short-Term Trading Plans - Newser
When is the best time to exit Medicus Pharma Ltd. Equity WarrantPortfolio Growth Summary & AI Driven Stock Reports - Newser
How high can Medicus Pharma Ltd. stock goPrice Action & Precise Entry and Exit Recommendations - Newser
Medicus Pharma Ltd Stock (MDCX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.30%
1.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):